Companies: 10,795·Total market cap: $144.5T
Abiomed, Inc.

Abiomed, Inc.

ABMDNASDAQHealthcare
$381.02
+$0.00(+0.00%)
Market Cap$17.2B
P/E Ratio
52W High$381.99
52W Low$219.845
Overview

Abiomed, Inc.(ABMD)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · ABMD · 截至 Jun 9, 2026

关键指标

EPS (TTM)$5.88abmd eps ttm · abmd earnings per shareEarnings history
PE Ratio (TTM)64.8×abmd pe ratio ttm · abmd price to earningsPE Ratio deep dive
Revenue (TTM)$1.1Babmd revenue ttm · abmd annual revenueFull revenue history
Dividend Yield不分红does abmd pay dividends · abmd dividend yieldDividend history
Shares Outstanding45.4Mabmd shares outstanding · abmd floatShares outstanding history
Next EarningsTBAabmd earnings date · abmd next earningsEarnings history

财务快照

完整财报
FY 2022Revenue$1.03B▲ +21.74% YoY
202020212022
abiomed, inc. revenue · abmd revenue 2022
FY 2022Net Income$136.5M▼ 39.47% YoY
202020212022
abiomed, inc. net income · abmd profit 2022
FY 2022EPS$3.00▼ 40.00% YoY
202020212022
abmd eps · abiomed, inc. earnings per share 2022
TTM:Revenue: $1.07BNet Income: $266.8MEPS: $5.88View income statement →

分析师评级与目标价

完整预测
SellBuy
Hold18 位分析师is abmd a buy · abmd analyst rating
Strong Buy
0
Buy
8
Hold
10
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$381.02Current
$Avg Target
$High
abmd price target · abmd 12 month forecast

合计: 18 · 买入占比: 44.4%

股票表现

完整历史
1D+0.00%
1W+0.00%
1M+0.00%
3M+1.88%
YTD+0.00%
1Y+31.19%
5Y+63.02%

关于 Abiomed, Inc.

CEOMichael Minogue
IPO DateJul 29, 1987
Employees2,003
CountryUS

Abiomed, Inc. specializes in the creation and distribution of advanced medical technology designed to support or substitute the heart's pumping action in patients suffering from heart failure, while a…

what is abiomed, inc. · abmd stock overview · abiomed, inc. company profile · who is abiomed, inc. ceo · abmd NASDAQ · abiomed, inc. headquarters · abiomed, inc. business segments

关于股票概览与关键数据

Abiomed, Inc.(ABMD)是 Medical - Devices 行业的 Healthcare 类公司,于 Jul 29, 1987 在 NASDAQ 上市。截至最近交易日,ABMD 股价为 $381.02,市值约为 $17.2B。过去12个月累计回报 +31.19%,年初至今回报 +0.00%。

根据 18 位华尔街分析师,Abiomed, Inc. 股票共识评级为Hold,12个月平均目标价为 $—。2022 财年 Abiomed, Inc. 营收 $1.0B,净利润 $136.5M。更多数据(营收历史、盈利、股息、市盈率)请使用上方标签页。

常见问题

截至最近一个交易日,Abiomed, Inc.(ABMD)股价为 $381.02,在 NASDAQ 上市,52周区间为 $219.84 – $381.99。

ABMD 最新股价ABMD quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议